Mirae Asset Global Investments
BHVN

Mirae Asset Global Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Mirae Asset Global Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,380
Closed -$3.99M – 2681
2022
Q3 		$3.99M Buy
26,380
+8,560
+48% +$1.27M 0.01% 892
2022
Q2 		$2.6M Buy
+17,820
New +$2.28M 0.01% 1057
2021
Q2 		– Sell
-14,364
Closed -$982K – 1768
2021
Q1 		$982K Sell
14,364
-803
-5% -$64.9K ﹤0.01% 1136
2020
Q4 		$1.3M Sell
15,167
-10,873
-42% -$921K ﹤0.01% 1062
2020
Q3 		$1.65M Buy
26,040
+8,680
+50% +$569K 0.01% 827
2020
Q2 		$1.27M Buy
+17,360
New +$924K 0.01% 835
2018
Q4 		– Sell
-30,000
Closed -$1.13M – 1406
2018
Q3 		$1.13M Buy
+30,000
New +$1.1M 0.01% 799

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Mirae Asset Global Investments's BHVN Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 26,380 shares — an estimated $3.99M sold.

Mirae Asset Global Investments first reported a position in BHVN in Q3 2018 and held it in 7 quarters. The position peaked at $3.99M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 26,380 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $3.99M.
  • Mirae Asset Global Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2018 and held it in 7 quarters.
  • Mirae Asset Global Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.99M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.